321 related articles for article (PubMed ID: 21397006)
1. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.
Counts SE; Che S; Ginsberg SD; Mufson EJ
J Chem Neuroanat; 2011 Oct; 42(2):111-7. PubMed ID: 21397006
[TBL] [Abstract][Full Text] [Related]
2. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.
Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE
Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871
[TBL] [Abstract][Full Text] [Related]
3. Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.
Perez SE; Getova DP; He B; Counts SE; Geula C; Desire L; Coutadeur S; Peillon H; Ginsberg SD; Mufson EJ
Am J Pathol; 2012 Feb; 180(2):526-40. PubMed ID: 22142809
[TBL] [Abstract][Full Text] [Related]
4. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease.
Mufson EJ; Ma SY; Dills J; Cochran EJ; Leurgans S; Wuu J; Bennett DA; Jaffar S; Gilmor ML; Levey AI; Kordower JH
J Comp Neurol; 2002 Feb; 443(2):136-53. PubMed ID: 11793352
[TBL] [Abstract][Full Text] [Related]
5. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease.
Ginsberg SD; Che S; Wuu J; Counts SE; Mufson EJ
J Neurochem; 2006 Apr; 97(2):475-87. PubMed ID: 16539663
[TBL] [Abstract][Full Text] [Related]
6. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease.
Counts SE; Nadeem M; Wuu J; Ginsberg SD; Saragovi HU; Mufson EJ
Ann Neurol; 2004 Oct; 56(4):520-31. PubMed ID: 15455399
[TBL] [Abstract][Full Text] [Related]
7. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease.
Mufson EJ; Ma SY; Cochran EJ; Bennett DA; Beckett LA; Jaffar S; Saragovi HU; Kordower JH
J Comp Neurol; 2000 Nov; 427(1):19-30. PubMed ID: 11042589
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease.
Chu Y; Cochran EJ; Bennett DA; Mufson EJ; Kordower JH
J Comp Neurol; 2001 Aug; 437(3):296-307. PubMed ID: 11494257
[TBL] [Abstract][Full Text] [Related]
9. Cholinotrophic molecular substrates of mild cognitive impairment in the elderly.
Mufson EJ; Counts SE; Fahnestock M; Ginsberg SD
Curr Alzheimer Res; 2007 Sep; 4(4):340-50. PubMed ID: 17908035
[TBL] [Abstract][Full Text] [Related]
10. Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease.
Counts SE; Chen EY; Che S; Ikonomovic MD; Wuu J; Ginsberg SD; Dekosky ST; Mufson EJ
Dement Geriatr Cogn Disord; 2006; 21(4):205-14. PubMed ID: 16410678
[TBL] [Abstract][Full Text] [Related]
11. The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease.
Counts SE; Mufson EJ
J Neuropathol Exp Neurol; 2005 Apr; 64(4):263-72. PubMed ID: 15835262
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease.
Mufson EJ; Counts SE; Ginsberg SD
Neurochem Res; 2002 Oct; 27(10):1035-48. PubMed ID: 12462403
[TBL] [Abstract][Full Text] [Related]
13. Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.
Vana L; Kanaan NM; Ugwu IC; Wuu J; Mufson EJ; Binder LI
Am J Pathol; 2011 Nov; 179(5):2533-50. PubMed ID: 21945902
[TBL] [Abstract][Full Text] [Related]
14. Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease.
Counts SE; He B; Che S; Ikonomovic MD; DeKosky ST; Ginsberg SD; Mufson EJ
Arch Neurol; 2007 Dec; 64(12):1771-6. PubMed ID: 18071042
[TBL] [Abstract][Full Text] [Related]
15. Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease.
Lad SP; Neet KE; Mufson EJ
Curr Drug Targets CNS Neurol Disord; 2003 Oct; 2(5):315-34. PubMed ID: 14529363
[TBL] [Abstract][Full Text] [Related]
16. Direct, complex effects of estrogens on basal forebrain cholinergic neurons.
Bora SH; Liu Z; Kecojevic A; Merchenthaler I; Koliatsos VE
Exp Neurol; 2005 Aug; 194(2):506-22. PubMed ID: 15893308
[TBL] [Abstract][Full Text] [Related]
17. Reduction in TrkA-immunoreactive neurons is not associated with an overexpression of galaninergic fibers within the nucleus basalis in Down's syndrome.
Sendera TJ; Ma SY; Jaffar S; Kozlowski PB; Kordower JH; Mawal Y; Saragovi HU; Mufson EJ
J Neurochem; 2000 Mar; 74(3):1185-96. PubMed ID: 10693951
[TBL] [Abstract][Full Text] [Related]
18. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction.
Mufson EJ; Ginsberg SD; Ikonomovic MD; DeKosky ST
J Chem Neuroanat; 2003 Dec; 26(4):233-42. PubMed ID: 14729126
[TBL] [Abstract][Full Text] [Related]
19. Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease.
Boissière F; Hunot S; Faucheux B; Hersh LB; Agid Y; Hirsch EC
Dement Geriatr Cogn Disord; 1997; 8(1):1-8. PubMed ID: 8997546
[TBL] [Abstract][Full Text] [Related]
20. HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease.
Mahady L; Nadeem M; Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ
Neuropathol Appl Neurobiol; 2019 Jun; 45(4):380-397. PubMed ID: 30252960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
